非典型颅内脑膜瘤术后复发的相关危险因素:单神经外科中心263例分析
该单中心回顾性分析纳入2009年10月至2018年9月手术的263例非典型脑膜瘤患者,中位随访41个月、中位无进展生存28个月,61例(23.2%)复发;Cox多因素分析显示MIB-1标记指数、继发性肿瘤、肿瘤大小和切除程度为复发独立预测因素;次全切除患者术后放疗与复发减少相关,全切除患者则无此关联。
要点
- MIB-1标记指数、继发性肿瘤、肿瘤大小和切除程度是非典型脑膜瘤复发的独立预测因素。
- 全切除患者中术后放疗未降低复发风险(p=0.923),次全切除患者中放疗与复发减少相关(p=0.023)。
- 6例接受3次以上手术者随复发次数增加,复发时间缩短且MIB-1标记指数升高。
核心结论
- MIB-1标记指数、继发性肿瘤、肿瘤大小和切除程度是非典型脑膜瘤患者复发的强预测因素。
- 全切除患者术后放疗未降低复发风险。
研究设计与样本
- 单神经外科中心回顾性分析,纳入2009年10月至2018年9月接受手术的263例非典型脑膜瘤患者。
- 分析因素包括手术切除程度、MIB-1标记指数、脑侵袭和治疗方式,采用单因素和多因素分析评估复发相关预后因素。
主要发现
- 中位随访时间41个月,中位无进展生存期28个月。
- 213例(81.0%)实现全切除,86例(32.7%)接受术后放疗,随访期间61例(23.2%)肿瘤复发。
- Cox多因素分析显示,MIB-1标记指数风险比2.637(p<0.001)、继发性肿瘤风险比3.541(p<0.001)、肿瘤大小风险比1.818(p=0.032)和切除程度风险比2.861(p<0.001)为肿瘤复发的独立显著预测因素。
- 放疗与次全切除患者肿瘤复发减少相关(p=0.023),与全切除患者复发无显著关联(p=0.923)。
- 对6例接受3次以上手术的脑膜瘤患者的分析提示,随着复发次数增加,复发时间缩短且MIB-1标记指数升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Atypical meningioma (AM) has a high rate of local recurrence after surgery, and the role of adjuvant radiotherapy in AM remains controversial. We analysed progression-free survival (PFS) and identified the factors associated with postoperative recurrence in AM patients. METHODS: Data were obtained from 263 AM patients who underwent surgery at our institution between October 2009 and September 2018. Analyses included factors such as the extent of surgical resection, MIB-1 labelling index, brain invasion and therapy modality. Univariate and multivariate analyses were used to assess recurrence-related prognostic factors. RESULT: The median follow-up duration was 41 months, and the median PFS was 28 months. Gross total resection (GTR) was achieved in 213 (81.0%) patients, and 86 (32.7%) patients received postoperative radiation therapy (RT). During follow-up, there were 61 (23.2%) tumour recurrences. In a Cox multivariate analysis, MIB-1 labelling index (hazard ratio = 2.637; p < 0.001), secondary tumour (hazard ratio = 3.541; p < 0.001), tumour size (hazard ratio = 1.818; p = 0.032) and extent of resection (hazard ratio = 2.861; p < 0.001) were independent significant predictors of tumour recurrence. RT was associated with reduced tumour recurrence in subtotal resection (STR) (p = 0.023) but not GTR (p = 0.923). An analysis of 6 meningioma patients who underwent more than 3 operations suggested that the recurrence time became shorter and the MIB-1 labelling index increased as the number of recurrences increased. CONCLUSIONS: MIB-1 labelling index, secondary tumour, tumour size and extent of resection were powerful predictors of recurrence in AM patients. Postoperative RT did not decrease the risk of recurrence in GTR patients.
引用
- Wang F, Xu D, Liu Y, et al. Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre. Acta Neurochir (Wien). 2019. PMID: 31641861. doi:10.1007/s00701-019-04073-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。